Functional recovery in parkinsonian monkeys treated with GDNF

Primate models of movement disorders of basal ganglia origin

DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824 · see citing works

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · see citing works

New stereological methods for counting neurons

West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940 · see citing works

Biochemical pathophysiology of Parkinson's disease.

Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 850 · see citing works

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A., & Hefti, F. F. (1995) · Nature · doi:10.1038/373339a0 · Cited by 654 · see citing works

A consideration of neural counting methods

Coggeshall, R. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90339-a · Cited by 540 · see citing works

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

Hoffer, B. J., Hoffman, A. F., Bowenkamp, K., Huettl, P. F., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453 · see citing works

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

Kearns, C. M., & Gash, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01366-p · Cited by 379 · see citing works

Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., & Kopin, I. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90431-5 · Cited by 308 · see citing works

Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons

Bowenkamp, K. E., Hoffman, A. F., Gerhardt, G. A., Henry, M. A., Biddle, P. T., Hoffer, B. J., & Granholm, A. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903550402 · Cited by 290 · see citing works

Overview of morphological changes in Parkinson's disease.

Jellinger, K. A. (1987) · PubMed · Cited by 271 · see citing works

Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo

Hudson, J., Granholm, A., Gerhardt, G. A., Henry, M. A., Hoffman, A. F., Biddle, P., LEELA, N. S., Mackerlova, L., Lile, J. D., Collins, F., et al. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00224-o · Cited by 242 · see citing works

Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms

Robertson, G. S., & Robertson, H. A. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-09-03326.1989 · Cited by 199 · see citing works

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

Greenamyre, J. T., Eller, R. V., Zhang, Z., Ovadia, A., Kurlan, R., & Gash, D. M. (1994) · Annals of Neurology · doi:10.1002/ana.410350605 · Cited by 152 · see citing works

Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys

Ovadia, A., Zhang, Z., & Gash, D. M. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02012-8 · Cited by 127 · see citing works

Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys

Gash, D. M., Zhang, Z., Cass, W. A., Ovadia, A., Simmerman, L. A., Martin, D., Russell, D. A., Collins, F., Hoffer, B. J., & Gerhardt, G. A. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903630302 · Cited by 118 · see citing works

Developing a stable bilateral model of parkinsonism in rhesus monkeys

Smith, R. D., Zhang, Z., Kurlan, R., McDermott, M., & Gash, D. M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90176-g · Cited by 104 · see citing works

Practical considerations for the use of the optical disector in estimating neuronal number

Harding, A., Halliday, G. M., & Cullen, K. M. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90028-0 · Cited by 88 · see citing works

Trophism, Transplantation, and Animal Models of Parkinson's Disease

Bankiewicz, K. S., Mandel, R. J., & Sofroniew, M. V. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1185 · Cited by 82 · see citing works

Evidence that the substantia nigra is a site of action for l-DOPA

Robertson, G. S., & Robertson, H. A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90382-5 · Cited by 65 · see citing works

Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.

Double, K. L., & Crocker, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1669 · Cited by 44 · see citing works

Parkinson's Disease

Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

Apoptosis in neurodegenerative disorders

Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605 · see citing works

Parkinson's disease

Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,305 · see citing works

Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290 · see citing works

Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease

Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J. L., Chen, E., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,244 · see citing works

Renal agenesis and the absence of enteric neurons in mice lacking GDNF

Sánchez, M. P., Silos‐Santiago, I., Frisén, J., He, B., Lira, S. A., & Barbacid, M. (1996) · Nature · doi:10.1038/382070a0 · Cited by 1,196 · see citing works

Defects in enteric innervation and kidney development in mice lacking GDNF

Pichel, J. G., Shen, L., SHENG, H. Z., Granholm, A., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J., et al. (1996) · Nature · doi:10.1038/382073a0 · Cited by 1,153 · see citing works

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · see citing works

The scientific and clinical basis for the treatment of Parkinson disease (2009)

Olanow, C. W., Stern, M. B., & Sethi, K. D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 918 · see citing works

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

Nutt, J. G., Burchiel, K. J., Comella, C., Jankovic, J. J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M. A., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 816 · see citing works

Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP

Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803 · see citing works

Toxin-induced models of Parkinson’s disease

Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739 · see citing works

Functional and pathophysiological models of the basal ganglia

Wichmann, T., & DeLong, M. R. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80024-9 · Cited by 724 · see citing works

An algorithm (decision tree) for the management of Parkinson’s disease (2001):

Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 718 · see citing works

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

Marks, W. J., Bartus, R. T., Siffert, J. O., Davis, C. S., Lozano, A. M., Boulis, N. M., Vitek, J. L., Stacy, M. A., Turner, D. A., Verhagen, L., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70254-4 · Cited by 685 · see citing works

Experimental models of Parkinson's disease

Beal, M. F. (2001) · Nature reviews. Neuroscience · doi:10.1038/35072550 · Cited by 634 · see citing works

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

Choi-Lundberg, D. L., Lin, Q., Chang, Y., Chiang, Y. L., Hay, C. M., Mohajeri, H. M., Davidson, B. L., & Bohn, M. C. (1997) · Science · doi:10.1126/science.275.5301.838 · Cited by 622 · see citing works

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

Marks, W. J., Ostrem, J. L., Verhagen, L., Starr, P. A., Larson, P. S., Bakay, R. A., Taylor, R., Cahn-Weiner, D. A., Stoessl, A. J., Olanow, C. W., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70065-6 · Cited by 596 · see citing works

Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor

Batchelor, P., Liberatore, G. T., Wong, J. Y. F., Porritt, M. J., Frerichs, F., Donnan, G. A., & Howells, D. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01708.1999 · Cited by 576 · see citing works

The role of neuronal growth factors in neurodegenerative disorders of the human brain

Connor, B. J., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 534 · see citing works

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513 · see citing works

Changes in cytokines and neurotrophins in Parkinson’s disease

Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_19 · Cited by 507 · see citing works

Persephin, a Novel Neurotrophic Factor Related to GDNF and Neurturin

Milbrandt, J., de Sauvage, F. J., Fahrner, T. J., Baloh, R. H., Leitner, M. L., Tansey, M. G., Lampe, P. A., Heuckeroth, R. O., Kotzbauer, P. T., Simburger, K. S., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80453-5 · Cited by 494 · see citing works

Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain

Siegel, G. J., & Chauhan, N. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00030-8 · Cited by 492 · see citing works

Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease

Lang, A. E., Lozano, A. M., Montgomery, E. B., Duff, J., Tasker, R. R., & Hutchinson, W. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371503 · Cited by 479 · see citing works

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line—derived neurotrophic factor

Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R. J., & Young, B. A. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.2.0216 · Cited by 474 · see citing works

Fetal Nigral Transplantation as a Therapy for Parkinson's Disease

Olanow, C. W., & Fahn, S. (2006) · Springer eBooks · doi:10.1007/0-387-32823-8_6 · Cited by 415 · see citing works

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00463-2 · Cited by 394 · see citing works

Intraputamenal infusion of glial cell line–derived neurotrophic factor in PD: A two‐year outcome study

Patel, N. K., Bunnage, M., Plaha, P., Svendsen, C. N., Heywood, P. G., & Gill, S. S. (2005) · Annals of Neurology · doi:10.1002/ana.20374 · Cited by 384 · see citing works

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

Maswood, N., Young, J., Tilmont, E. M., Zhang, Z., Gash, D. M., Gerhardt, G. A., Grondin, R., Roth, G. S., Mattison, J. A., Lane, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405831102 · Cited by 383 · see citing works

Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation

Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363 · see citing works

Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes

Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C. C., Wilson, B. C., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 352 · see citing works

TrnR2, a Novel Receptor That Mediates Neurturin and GDNF Signaling through Ret

Baloh, R. H., Tansey, M. G., Golden, J. P., Creedon, D. J., Heuckeroth, R. O., Keck, C. L., Zimonjic, D. B., Popescu, N. C., Johnson, E. M., & Milbrandt, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80318-9 · Cited by 351 · see citing works

Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells

Redmond, D. E., Bjugstad, K. B., Teng, Y. D., Ourednik, V., Ourednik, J., Wakeman, D. R., Parsons, X. H., Gonzalez, R., Blanchard, B. C., Kim, S. U., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704091104 · Cited by 340 · see citing works

Neurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons

Horger, B. A., Nishimura, M. C., Armanini, M. P., Wang, L.-C., Poulsen, K. T., Rosenblad, C., Kirik, D., Moffat, B., Simmons, L., Johnson, E., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04929.1998 · Cited by 338 · see citing works

Absolute requirement of GDNF for adult catecholaminergic neuron survival

Pascual, A., Hidalgo‐Figueroa, M., Piruat, J. I., Pintado, C. O., Gómez-Díaz, R., & López‐Barneo, J. (2008) · Nature Neuroscience · doi:10.1038/nn.2136 · Cited by 332 · see citing works

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats

Mandel, R. J., Spratt, S. K., Snyder, R. O., & Leff, S. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14083 · Cited by 328 · see citing works

The role of glial cells in Parkinsonʼs disease

Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326 · see citing works

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

Steiner, J. P., Hamilton, G. S., Ross, D. T., Valentine, H. L., Guo, H., Connolly, M. A., Liang, S., Ramsey, C., Li, J.-H. J., Huang, W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2019 · Cited by 324 · see citing works

Anatomy of the dopamine system in the basal ganglia

Smith, Y., & Kieval, J. Z. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00023-9 · Cited by 320 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex

Wang, Y., Lin, S., Chiou, A. L., Williams, L. R., & Hoffer, B. J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04341.1997 · Cited by 314 · see citing works

How to make a midbrain dopaminergic neuron

Arenas, E., Denham, M., & Villaescusa, C. (2015) · Development · doi:10.1242/dev.097394 · Cited by 306 · see citing works

Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson's Disease

Åkerud, P., Canals, J. M., Snyder, E. Y., & Arenas, E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08108.2001 · Cited by 303 · see citing works

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease

Bilang-Bleuel, A., Revah, F., Colin, P., Locquet, I., Robert, J.-J., Mallet, J., & Horellou, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8818 · Cited by 297 · see citing works

Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins

Sanicola, M., Hession, C. A., Worley, D. S., Carmillo, P., Ehrenfels, C. W., Walus, L. R., Robinson, S., Jaworski, G. J., Wei, H., Tizard, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6238 · Cited by 295 · see citing works

Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's Disease

Déglon, N., Tseng, J., Bensadoun, J. C., Zurn, A. D., Arsenijévic, Y., de Almeida, L. P., Zufferey, R., Trono, D., & Aebischer, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050016256 · Cited by 292 · see citing works

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

Alexi, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00032-5 · Cited by 290 · see citing works

Localized striatal delivery of GDNF as a treatment for Parkinson disease

Kirik, D., Georgievska, B., & Björklund, A. (2004) · Nature Neuroscience · doi:10.1038/nn1175 · Cited by 289 · see citing works

Gene delivery of neurturin to putamen and substantia nigra in P arkinson disease: A double‐blind, randomized, controlled trial

Olanow, C. W., Bartus, R. T., Baumann, T. L., Factor, S. A., Boulis, N. M., Stacy, M. A., Turner, D. A., Marks, W. J., Larson, P., Starr, P. A., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24436 · Cited by 287 · see citing works

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs

Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.136 · Cited by 285 · see citing works

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease

Whone, A., Luz, M., Boca, M., Woolley, M., Mooney, L., Dharia, S., Broadfoot, J., Cronin, D., Schroers, C., Barua, N. U., et al. (2019) · Brain · doi:10.1093/brain/awz023 · Cited by 282 · see citing works

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

Grondin, R., Zhang, Z., Ai, Y., Cass, W. A., Maswood, N., Andersen, A. H., Elsberry, D. D., Klein, M. C., Gerhardt, G. A., & Gash, D. M. (2002) · Brain · doi:10.1093/brain/awf234 · Cited by 280 · see citing works

Pathogenic role of glial cells in Parkinson's disease

Teismann, P., Tieu, K., Cohen, O. S., Choi, D., Wu, D. C., Marks, D., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2002) · Movement Disorders · doi:10.1002/mds.10332 · Cited by 272 · see citing works

Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease

Voutilainen, M. H., Bäck, S., Pörsti, E., Toppinen, L., Lindgren, L., Lindholm, P., Peränen, J., Saarma, M., & Tuominen, R. K. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0833-09.2009 · Cited by 269 · see citing works

Neurodegeneration and neuroprotection in Parkinson disease

Fahn, S., & Sulzer, D. L. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.1.139 · Cited by 266 · see citing works

Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system

Taraviras, S. L., Marcos-Gutierrez, C. V., Durbec, P. L., Jani, H., Grigoriou, M. E., Sukumaran, M., Wang, L.-C., Hynes, M., Raisman, G., & Pachnis, V. (1999) · Development · doi:10.1242/dev.126.12.2785 · Cited by 263 · see citing works

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

Rosenblad, C., Kirik, D., Devaux, B., Moffat, B., PHILLIPS, H. S., & Björklund, A. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00566.x · Cited by 261 · see citing works

Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson’s Disease

Winkler, C., Sauer, H., Lee, C. S., & Björklund, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07206.1996 · Cited by 258 · see citing works

Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys

Kordower, J. H., Herzog, C. D., Dass, B., Bakay, R. A. E., Stansell, J., Gasmi, M., & Bartus, R. T. (2006) · Annals of Neurology · doi:10.1002/ana.21032 · Cited by 251 · see citing works

Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease

Björklund, A., Rosenblad, C., Winkler, C., & Kirik, D. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0151 · Cited by 247 · see citing works

Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats

Wang, J., Wu, J.-N., Cherng, T.-L., Hoffer, B. J., Chen, H.-H., Borlongan, C. V., & Wang, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02450-7 · Cited by 242 · see citing works

Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system

Nosrat, I. V., Smith, C. A., Mullally, P., Olson, L., & Nosrat, C. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03314.x · Cited by 242 · see citing works

Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis

Hansford, J. R., & Mulligan, L. M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.817 · Cited by 237 · see citing works

NURR1 in Parkinson disease—from pathogenesis to therapeutic potential

Decressac, M., Volakakis, N., Björklund, A., & Perlmann, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.209 · Cited by 234 · see citing works

Biology of GDNF and its receptors — Relevance for disorders of the central nervous system

Ibáñez, C. F., & Andressoo, J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.021 · Cited by 234 · see citing works

Ablative Surgery and Deep Brain Stimulation for Parkinson's Disease

Starr, P. A., Vitek, J. L., & Bakay, R. A. E. (1998) · Neurosurgery · doi:10.1097/00006123-199811000-00001 · Cited by 230 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-β for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons

KRIEGLSTEIN, K. G., Henheik, P., Farkas, L. M., Jászai, J., Galter, D., Krohn, K., & Unsicker, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09822.1998 · Cited by 228 · see citing works

Cell death mechanisms in Parkinson's disease

Jellinger, K. A. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050001 · Cited by 227 · see citing works

Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system

Nosrat, C. A., Tomac, A. C., Lindqvist, E., Lindskog, S. F., Humpel, C., Strömberg, I., Ebendal, T., Hoffer, B. J., & Olson, L. (1996) · Cell and Tissue Research · doi:10.1007/s004410050688 · Cited by 226 · see citing works

Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain

Peden, C. S., Burger, C., Muzyczka, N., & Mandel, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6344-6359.2004 · Cited by 222 · see citing works

Involvement of basal ganglia transmitter systems in movement initiation

Hauber, W. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00041-0 · Cited by 222 · see citing works

Redox imbalance

Berg, D., Youdim, M. B. H., & Riederer, P. F. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 217 · see citing works

Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration

Palfi, S., Leventhal, L., Chu, Y., Ma, S. Y., Emborg, M. E., Bakay, R. A. E., Déglon, N., Hantraye, P., Aebischer, P., & Kordower, J. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04942.2002 · Cited by 215 · see citing works

Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach

Bézard, E., & Gross, C. E. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00006-9 · Cited by 213 · see citing works

Enriched Environment Confers Resistance to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine and Cocaine: Involvement of Dopamine Transporter and Trophic Factors

Bézard, E., Doveró, S., Belin, D., Duconger, S., Jackson-Lewis, V. R., Przedborski, S., Piazza, P. V., Gross, C. E., & Jaber, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-10999.2003 · Cited by 209 · see citing works

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

Chauhan, N. B., Siegel, G. J., & Lee, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00115-6 · Cited by 207 · see citing works

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factor

Kirik, D., Rosenblad, C., & Björklund, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00274.x · Cited by 206 · see citing works

Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

Eberhardt, O., von Coelln, R., Kügler, S., Lindenau, J. H., Rathke‐Hartlieb, S., Gerhardt, E., Haid, S., Isenmann, S., Gravel, C., Srinivasan, A. N., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09126.2000 · Cited by 206 · see citing works

Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse.

Frasson, M., Picaud, S. A., Léveillard, T., Simonutti, M., Mohand‐Saïd, S., Dreyfus, H., Hicks, D., & Sabel, J. L. (1999) · PubMed · Cited by 202 · see citing works

Presynaptic regulation of dopaminergic neurotransmission

Schmitz, Y., Benoit‐Marand, M., Gonon, F., & Sulzer, D. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02050.x · Cited by 198 · see citing works

Neurotrophic Mechanisms in Drug Addiction

Bolaños, C. A., & Nestler, E. J. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:069 · Cited by 195 · see citing works

Progress in Parkinson's disease—Where do we stand?

Toulouse, A., & Sullivan, A. M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.05.003 · Cited by 194 · see citing works

GDNF acutely modulates excitability and A-type K+ channels in midbrain dopaminergic neurons

Yang, F., Feng, L., Zheng, F., Johnson, S. W., Du, J., Shen, L., Wu, C.-P., & Lu, B. (2001) · Nature Neuroscience · doi:10.1038/nn734 · Cited by 193 · see citing works

Midbrain dopaminergic neurons: A review of the molecular circuitry that regulates their development

Hegarty, S. V., Sullivan, A. M., & O’Keeffe, G. W. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.04.014 · Cited by 190 · see citing works

MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain

Lindholm, P., Peränen, J., Andressoo, J., Kalkkinen, N., Kokaia, Z., Lindvall, O., Timmusk, T., & Saarma, M. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.016 · Cited by 187 · see citing works

Glial Cell Line Derived Neurotrophic Factor Delays Photoreceptor Degeneration in a Transgenic Rat Model of Retinitis Pigmentosa

Sanftner, L. H. M., Abel, H., Hauswirth, W. W., & Flannery, J. G. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0498 · Cited by 187 · see citing works

Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains

Smith, Y., & Villalba, R. M. (2008) · Movement Disorders · doi:10.1002/mds.22027 · Cited by 186 · see citing works

PHARMACOLOGY OF NEUROTROPHIC FACTORS

Hefti, F. F. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.239 · Cited by 186 · see citing works

Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Ramanan, V. K., & Saykin, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 185 · see citing works

Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNF

Bensadoun, J., Déglon, N., Tseng, J., Ridet, J., Zurn, A. D., & Aebischer, P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7409 · Cited by 183 · see citing works

Growth/Differentiation Factor-15/Macrophage Inhibitory Cytokine-1 Is a Novel Trophic Factor for Midbrain Dopaminergic NeuronsIn Vivo

Strelau, J., Sullivan, A. M., Bottner, M. B., Lingor, P., Falkenstein, E., Suter‐Crazzolara, C., Galter, D., Jászai, J., KRIEGLSTEIN, K. G., & Unsicker, K. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08597.2000 · Cited by 175 · see citing works

Unilateral intraputamenal glial cell line–derived neurotrophic factor in patients with Parkinson disease: Response to 1 year of treatment and 1 year of withdrawal

Slevin, J. T., Gash, D. M., Smith, C. D., Gerhardt, G. A., Kryscio, R., Chebrolu, H., Walton, A., Wagner, R., & Young, A. B. (2007) · Journal of neurosurgery · doi:10.3171/jns.2007.106.4.614 · Cited by 173 · see citing works

Differential Effects of Glial Cell Line‐Derived Neurotrophic Factor and Neurturin on Developing and Adult Substantia Nigra Dopaminergic Neurons

Åkerud, P., Alberch, J., Eketjäll, S., Wagner, J., & Arenas, E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730070.x · Cited by 171 · see citing works

Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains

Bartus, R. T., Herzog, C. D., Chu, Y., Wilson, A., Brown, L., Siffert, J. O., Johnson, E. M., Olanow, C. W., Mufson, E. J., & Kordower, J. H. (2010) · Movement Disorders · doi:10.1002/mds.23442 · Cited by 170 · see citing works

Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: A real-time PCR study

Bäckman, C. M., Shan, L., Zhang, Y. J., Hoffer, B. J., Leonard, S. S., Troncoso, J. C., Vonsatel, P., & Tomac, A. C. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.03.013 · Cited by 170 · see citing works

Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies

Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169 · see citing works

The Scientific Basis for the Current Treatment of Parkinson's Disease

Olanow, C. W. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104422 · Cited by 169 · see citing works

Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates

Behrstock, S. P., Ebert, A. D., McHugh, J., Vosberg, S. K., Moore, J. M., Schneider, B. L., Capowski, E. E., Hei, D. J., Kordower, J. H., Aebischer, P., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302679 · Cited by 168 · see citing works

Glial Cell Line-derived Neurotrophic Factor Signals through the RET Receptor and Activates Mitogen-activated Protein Kinase

Worby, C. A., Vega, Q. C., Zhao, Y., Chao, H. H.-J., Seasholtz, A. F., & Dixon, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23619 · Cited by 167 · see citing works

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

Grondin, R., Zhang, Z., Ai, Y., Cass, W. A., Maswood, N., Andersen, A. H., Elsberry, D. D., Klein, M. C., Gerhardt, G. A., & Gash, D. M. (2002) · Brain · doi:10.1093/brain/awf234 · Cited by 280 · see citing works

Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease

Grondin, R., & Gash, D. M. (1998) · Journal of Neurology · doi:10.1007/pl00007744 · Cited by 134 · see citing works

Trophic factor distribution predicts functional recovery in parkinsonian monkeys

Gash, D. M., Zhang, Z., Ai, Y., Grondin, R., Coffey, R. J., & Gerhardt, G. A. (2005) · Annals of Neurology · doi:10.1002/ana.20549 · Cited by 97 · see citing works

Neuroprotective and neurorestorative properties of GDNF

Gash, D. M., Zhang, Z., & Gerhardt, G. A. (1998) · Annals of Neurology · doi:10.1002/ana.410440718 · Cited by 160 · see citing works

Histological Effects of Intraputaminal Infusion of Glial Cell Line-Derived Neurotrophic Factor in Parkinson Disease Model Macaque Monkeys

Oiwa, Y., NAKAI, K., & Itakura, T. (2006) · Neurologia medico-chirurgica · doi:10.2176/nmc.46.267 · Cited by 21 · see citing works